LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

Search

Dr Reddy's Laboratories Ltd-ADR

Отворен

СекторЗдравеопазване

15.04 -1.83

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

14.96

Максимум

15.32

Ключови измерители

By Trading Economics

Приходи

1.8B

16B

Продажби

1.5B

85B

P/E

Средно за сектора

19.628

50.291

EPS

19.11

Дивидентна доходност

0.62

Марж на печалбата

18.66

Служители

27,811

EBITDA

985M

25B

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+10.24% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.62%

2.40%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

10B

13B

Предишно отваряне

16.87

Предишно затваряне

15.04

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

Dr Reddy's Laboratories Ltd-ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.05.2025 г., 18:56 ч. UTC

Печалби

Dr Reddy's Laboratories 4Q EPS INR19.11 >RDY

9.05.2025 г., 18:56 ч. UTC

Печалби

Dr Reddy's Laboratories 4Q Rev INR85.06B >RDY

23.01.2025 г., 17:46 ч. UTC

Печалби

Dr. Reddy's 3Q Net Attributable to Equity Holders of Parent Company INR14.13B

23.01.2025 г., 17:42 ч. UTC

Печалби

Dr. Reddy's 3Q Rev INR83.59B

5.11.2024 г., 11:01 ч. UTC

Печалби

Dr. Reddy's Laboratories 1H Rev INR156.89B Vs. INR136.19B >RDY

5.11.2024 г., 11:00 ч. UTC

Печалби

Dr. Reddy's Laboratories 1H Net INR26.47B Vs. Net INR28.825B >RDY

5.11.2024 г., 10:57 ч. UTC

Печалби

Dr. Reddy's Laboratories 2Q Net INR12.55B Vs. Net INR14.80B >RDY

5.11.2024 г., 10:57 ч. UTC

Печалби

Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY

Сравнение с други в отрасъла

Ценова промяна

Dr Reddy's Laboratories Ltd-ADR Прогноза

Ценова цел

By TipRanks

10.24% нагоре

12-месечна прогноза

Среден 16.9 USD  10.24%

Висок 16.9 USD

Нисък 16.9 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Dr Reddy's Laboratories Ltd-ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

N/A / 13.84Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Weak Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.